<DOC>
	<DOCNO>NCT02229773</DOCNO>
	<brief_summary>Lipid lower effect , investigation pharmacodynamics ( inhibition oxidosqualene cyclase , monoepoxysqualene ( MES ) marker ) , safety / tolerability preliminary pharmacokinetics</brief_summary>
	<brief_title>Pharmacodynamics , Preliminary Pharmacokinetics Tolerability BIBB 1464 ( Tablet ) Hyperlipemic Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pravastatin</mesh_term>
	<criteria>Healthy male Caucasian subject determine result screen Written informed consent accordance GCP local legislation give Age &gt; = 18 &lt; = 65 year Broca &gt; = 20 % &lt; = + 30 % LDLcholesterol level &gt; = 3.3 mmol/L prescreening two screen visit Any find medical examination . ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal ( include thyroid ) disorder Surgery gastrointestinal tract ( except appendectomy ) Disease central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( &lt; = 1 month prior administration trial ) Use drug might influence result trial ( &lt; = 10 day prior administration trial ) Participation another trial investigational drug ( &lt; = 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke period study Alcohol abuse ( &gt; 60/g/day ) Drug abuse Blood donation ( &gt; 400ml &lt; =1 month prior administration ) Excessive physical activity ( &lt; =5 day prior administration ) Any laboratory value outside normal range clinical relevance LDL cholesterol screen measurement day 1 day 7 different two value exceed 12 % high dose subject vegetarian Eyelens Cataract extraction one eye deem likely within 2 year ( `` senile '' , nonidiopathic automatically exclude patient participation ) Lens Opacities Classification System ( LOCS ) III grade &gt; 3.0 ( nuclear opalescence cortical grad ) &gt; 0.5 ( posterior sub capsular grad ) Log MAR BaileyLovie visual acuity &gt; 0.5 Corneal conjunctival problem would preclude lens photography Shallow anterior chamber risk angleclosure glaucoma Pupil dilate least 6 mm Visually significant fundus pathology clinician 's judgment Amblyopia , optic nerve disease , iritis , history eye surgery , argon YAG laser , major eye trauma , extend use ( daily &gt; 3 month ) ocular systemic corticosteroid treatment , use anticoagulant , glaucoma therapy , participation another clinical trial investigation anticataract cataractogenic formulation within last year</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>